• About us
• Contact

Advertisement

Organisation › Details

Entelechon GmbH

Entelechon GmbH was founded in 1999 as one of the first companies dedicated to synthetic biology. Entelechon's portfolio includes gene synthesis and molecular biology services with main applications in the pharmaceutical industry for developing new drugs, vaccines and diagnostic solutions. A spin-off, PolyQuant GmbH, is dedicated to targeted proteomics and provides multiplex protein quantification by the means of the QconCAT technology. *

 

	Start	1999-01-01 splitoff
	Group	Eurofins (Group)
	Person	Fischer, Markus (PolyQuant 201306 Managing Director + Entelechon GmbH 200709 Managing Director)
	Street	1 Industriestr.
	City	93077 Bad Abbach
	Tel	+49-9405-96999-10
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2025-07-06

Advertisement

More documents for Eurofins (Group)

• [1] SGS S.A.. (12/18/23). "Press Release: SGS Signs Agreement to Divest Crop Science Operations to Eurofins Scientific [ Ad hoc announcement pursuant to Art. 53 LR ] "....
• [2] Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg....
• [3] Berkeley Lights, Inc.. (3/9/22). "Press Release: Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer". Emeryville, CA....
• [4] Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA....
• [5] Eurofins Scientific. (4/16/20). "Press Release: Eurofins Genomics Launches »SARS-CoV-2 Full-length Genome Sequencing« Service to Support Researchers Globally in Their Fight against the COVID-19 Pandemic and Outbreak Source Tracing". Ebersberg....
• [6] Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY....
• [7] Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg....
• [8] Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg....
• [9] Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.